AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 70 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,405,000 | -50.5% | 50,000 | -33.3% | 0.09% | -47.2% |
Q2 2019 | $2,840,000 | -27.2% | 75,000 | -25.0% | 0.16% | -38.3% |
Q1 2019 | $3,902,000 | +50.3% | 100,000 | -17.9% | 0.26% | +25.1% |
Q4 2018 | $2,597,000 | -47.5% | 121,797 | -2.6% | 0.21% | -34.5% |
Q3 2018 | $4,949,000 | -59.9% | 125,000 | -61.3% | 0.32% | -64.7% |
Q2 2018 | $12,340,000 | +27.2% | 322,945 | 0.0% | 0.91% | +26.3% |
Q1 2018 | $9,704,000 | -8.1% | 322,945 | -4.4% | 0.72% | -34.6% |
Q4 2017 | $10,559,000 | +16.5% | 337,876 | +4.4% | 1.10% | -30.9% |
Q3 2017 | $9,062,000 | +46.4% | 323,545 | 0.0% | 1.60% | +55.9% |
Q2 2017 | $6,189,000 | -14.5% | 323,545 | -23.8% | 1.03% | -2.4% |
Q1 2017 | $7,236,000 | -11.9% | 424,660 | -5.6% | 1.05% | -5.1% |
Q4 2016 | $8,215,000 | +2.6% | 449,660 | 0.0% | 1.11% | +25.4% |
Q3 2016 | $8,008,000 | – | 449,660 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |